Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain

被引:36
|
作者
Bao, F
Arai, H
Matsushita, S
Higuchi, S
Sasaki, H
机构
[1] TOHOKU UNIV,SCH MED,DEPT GERIATR MED,SENDAI,MIYAGI 980,JAPAN
[2] KURIHAMA NATL HOSP,NATL INST ALCOHOLISM,DEPT PSYCHIAT,KANAGAWA 239,JAPAN
关键词
apolipoprotein E; Alzheimer's disease; progressive supranuclear palsy; diffuse Lewy body disease; Parkinson's disease; immunohistochemistry; immunoblot analysis;
D O I
10.1097/00001756-199607290-00008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BRAINS from 21 patients with Alzheimer's disease (AD), nine with diffuse Lewy body disease (DLBD), six with progressive supranuclear palsy (PSP) and five with Parkinson's disease (PD) as well as 20 normal subjects were examined to detect apolipoprotein E (ApoE) by immunohistochemistry and immunoblotting. ApoE antigenicity was optimally preserved in Bouin-fixed tissues compared with those fixed in neutral-buffered formalin, 70% ethanol or denatured by microwave energy. ApoE immunoreactivity was prominent in senile plaques and in intra- and extra-neuronal tangles, as well as in a diverse neurones and their processes and astroglial cells. Notably, tangles in PSP and Lewy bodies in PD and DLBD were both devoid of ApoE immunoreactivity. Western blots of cerebral cortex revealed an immunoreactive ApoE band with mel. wt of 34 kDa. Our results suggest that ApoE is not a crucial factor in the development of neuronal inclusions in DLBD, PSP and PD.
引用
收藏
页码:1733 / 1739
页数:7
相关论文
共 50 条
  • [31] Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease
    Buttini, M
    Akeefe, H
    Lin, C
    Mahley, RW
    Pitas, RE
    Wyss-Coray, T
    Mucke, L
    NEUROSCIENCE, 2000, 97 (02) : 207 - 210
  • [32] Apolipoprotein E and disease
    PedroBotet, J
    RubiesPrat, J
    MEDICINA CLINICA, 1997, 109 (06): : 216 - 218
  • [33] ASSOCIATION OF APOLIPOPROTEIN-E GENOTYPE WITH BRAIN LEVELS OF APOLIPOPROTEIN-E, J AND D IN ALZHEIMERS-DISEASE
    DEA, D
    BERTRAND, P
    PASINETTI, GM
    FINCH, CE
    TERRISSE, L
    RASSART, E
    POIRIER, J
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S97 - S97
  • [34] Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain
    Thangavel, Ramasamy
    Bhagavan, Sachin M.
    Ramaswamy, Swathi Beladakere
    Surpur, Spurthi
    Govindarajan, Raghav
    Kempuraj, Duraisamy
    Zaheer, Smita
    Raikwar, Sudhanshu
    Ahmed, Mohammad E.
    Selvakumar, Govindhasamy Pushpavathi
    Iyer, Shankar S.
    Zaheer, Asgar
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 553 - 560
  • [35] TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
    Mccoy, Melissa K.
    Tansey, Malu G.
    JOURNAL OF NEUROINFLAMMATION, 2008, 5 (1)
  • [36] TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
    Melissa K McCoy
    Malú G Tansey
    Journal of Neuroinflammation, 5
  • [37] A quantitative study of abnormally enlarged neurons in cognitively normal brain and neurodegenerative disease
    Armstrong, Richard A.
    CLINICAL NEUROPATHOLOGY, 2013, 32 (02) : 128 - 134
  • [38] Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease
    Bales, Kelly R.
    NEUROPHARMACOLOGY, 2010, 59 (4-5) : 295 - 302
  • [39] Apolipoprotein E receptors: linking brain development and alzheimer's disease
    Joachim Herz
    Uwe Beffert
    Nature Reviews Neuroscience, 2000, 1 : 51 - 58
  • [40] Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
    Butterfield, D. Allan
    Mattson, Mark P.
    NEUROBIOLOGY OF DISEASE, 2020, 138